{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:15:59Z","timestamp":1790140559423,"version":"4.0.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T00:00:00Z","timestamp":1611878400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T00:00:00Z","timestamp":1611878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Key R&D Program of China","award":["Nos. 2018YFC1314000"],"award-info":[{"award-number":["Nos. 2018YFC1314000"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.81774043"],"award-info":[{"award-number":["No.81774043"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019065","name":"Tianjin Science and Technology Plan Project","doi-asserted-by":"crossref","award":["No.17ZXMFSY00140"],"award-info":[{"award-number":["No.17ZXMFSY00140"]}],"id":[{"id":"10.13039\/501100019065","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006606","name":"Natural Science Foundation of Tianjin City","doi-asserted-by":"publisher","award":["No.17JCZDJC34700"],"award-info":[{"award-number":["No.17JCZDJC34700"]}],"id":[{"id":"10.13039\/501100006606","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Scientific Research Funding of Tianjin Medical University Chu Hsien-I Memorial Hospital","award":["2018ZDKF06"],"award-info":[{"award-number":["2018ZDKF06"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Aims\/Introduction<\/jats:title>\n                <jats:p>The relationship between urinary excretion rate of glucose (UEGL) and uric acid (UA) metabolism in adults with type 2 diabetes (T2D) remains unclear to date. This study aimed to investigate the relationships of UEGL with serum UA (SUA), urinary excretion rate of uric acid (UEUA), and renal clearance of uric acid (CLUA) in adults with T2D. We hypothesised that high UEGL increases UA excretion, which in turn leads to lower SUA.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Materials and methods<\/jats:title>\n                <jats:p>This was a cross-sectional study of 635 inpatients with T2D recruited between 2018 and 2019. The relationships of UEGL with UEUA, CLUA, and hyperuricaemia were assessed using analysis of covariance and multivariate regression analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Patients in the higher quartile of UEGL tended to have lower SUA levels than those in the lower quartile. In contrast, patients in the higher quartile of UEGL tended to have higher CLUA (<jats:italic>p<\/jats:italic> for trend\u2009&lt;\u20090.0001), and a similar trend was observed for UEUA. In adjusted multivariable linear regression model, UEGL was negatively correlated with SUA (<jats:italic>\u03b2<\/jats:italic>\u2009=\u2009\u2212\u00a00.023, 95% CI\u2009\u2212\u00a00.034 to \u2212\u00a00.013, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001). However, positive correlations of UEGL with UEUA (\u03b2\u2009=\u20090.046, 95% CI\u20090.018\u20130.074, <jats:italic>p<\/jats:italic>\u2009=\u20090.001) and CLUA (<jats:italic>\u03b2<\/jats:italic>\u2009=\u20090.063, 95% CI\u20090.042\u20130.085, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001) were found. Furthermore, consistent significant inverse associations were observed between quartiles of UEGL and hyperuricaemia in the adjusted multivariate logistic regression model.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>A high UEGL level was positively correlated with UEUA and CLUA. Moreover, it was inversely associated with SUA level, and a consistently increased UEGL level reduced the risk of hyperuricaemia in patients with T2D.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s40618-021-01513-8","type":"journal-article","created":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T19:02:52Z","timestamp":1611946972000},"page":"1981-1988","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["High urinary excretion rate of glucose attenuates serum uric acid level in type 2 diabetes with normal renal function"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8148-0864","authenticated-orcid":false,"given":"Y.","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6674-6644","authenticated-orcid":false,"given":"B.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,29]]},"reference":[{"issue":"5","key":"1513_CR1","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.jare.2016.11.004","volume":"8","author":"UAA Sharaf El Din","year":"2017","unstructured":"Sharaf El Din UAA, Salem MM, Abdulazim DO (2017) Uric acid in the pathogenesis of metabolic, renal, and cardiovascular diseases: A REVIEW. J Adv Res 8(5):537\u2013548. https:\/\/doi.org\/10.1016\/j.jare.2016.11.004","journal-title":"J Adv Res"},{"issue":"18","key":"1513_CR2","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1001\/jama.283.18.2404","volume":"283","author":"J Fang","year":"2000","unstructured":"Fang J, Alderman MH (2000) Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971\u20131992. National Health and Nutrition Examination Survey. JAMA 283(18):2404\u20132410. https:\/\/doi.org\/10.1001\/jama.283.18.2404","journal-title":"JAMA"},{"issue":"6","key":"1513_CR3","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.2337\/dc18-2147","volume":"42","author":"Bjornstad P, Laffel L, Lynch J, El Ghormli, L, Weinstock RS, Tollefsen SE, Nadeau KJ, TODAY Study Group","year":"2019","unstructured":"Bjornstad P, Laffel L, Lynch J, El Ghormli, L, Weinstock RS, Tollefsen SE, Nadeau KJ, TODAY Study Group (2019) Elevated Serum Uric Acid Is Associated With Greater Risk for Hypertension and Diabetic Kidney Diseases in Obese Adolescents With Type 2 Diabetes: An Observational Analysis From the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Study. Diabetes Care 42(6):1120\u20131128. https:\/\/doi.org\/10.2337\/dc18-2147","journal-title":"Diabetes Care"},{"issue":"8292","key":"1513_CR4","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/s0140-6736(82)90324-5","volume":"2","author":"JB Herman","year":"1982","unstructured":"Herman JB, Goldbourt U (1982) Uric acid and diabetes: observations in a population study. Lancet 2(8292):240\u2013243. https:\/\/doi.org\/10.1016\/s0140-6736(82)90324-5","journal-title":"Lancet"},{"issue":"10","key":"1513_CR5","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1055\/s-2007-979093","volume":"29","author":"L Gonz\u00e1lez-Sicilia","year":"1997","unstructured":"Gonz\u00e1lez-Sicilia L, Garc\u00eda-Esta\u00f1 J, Mart\u00ednez-Bl\u00e1zquez A, Fern\u00e1ndez-Pardo J, Quiles JL, Hern\u00e1ndez J (1997) Renal metabolism of uric acid in type I insulin-dependent diabetic patients: relation to metabolic compensation. Horm Metab Res 29(10):520\u2013523. https:\/\/doi.org\/10.1055\/s-2007-979093","journal-title":"Horm Metab Res"},{"issue":"5","key":"1513_CR6","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1093\/rheumatology\/ken066","volume":"47","author":"HK Choi","year":"2008","unstructured":"Choi HK, Ford ES (2008) Haemoglobin A1c, fasting glucose, serum C-peptide and insulin resistance in relation to serum uric acid levels\u2013the Third National Health and Nutrition Examination Survey. Rheumatology (Oxford) 47(5):713\u2013717. https:\/\/doi.org\/10.1093\/rheumatology\/ken066","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"1513_CR7","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/0009-8981(82)90376-x","volume":"120","author":"A Gotfredsen","year":"1982","unstructured":"Gotfredsen A, McNair P, Christiansen C, Transb\u00f8l I (1982) Renal hypouricaemia in insulin treated diabetes mellitus. Clin Chim Acta 120(3):355\u2013361. https:\/\/doi.org\/10.1016\/0009-8981(82)90376-x","journal-title":"Clin Chim Acta"},{"issue":"5","key":"1513_CR8","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/ckj\/sft100","volume":"6","author":"I Aires","year":"2013","unstructured":"Aires I, Santos AR, Pratas J, Nolasco F, Calado J (2013) Hypouricaemia and hyperuricosuria in familial renal glucosuria. Clin Kidney J 6(5):523\u2013525. https:\/\/doi.org\/10.1093\/ckj\/sft100","journal-title":"Clin Kidney J"},{"issue":"2","key":"1513_CR9","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/dom.13101","volume":"20","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, Xu L, Tian D, Xia P, Zheng H, Wang L, Chen L (2018) Effects of sodium-glucose co-transporter 2 (SGLT2) inhibitors on serum uric acid level: A meta-analysis of randomized controlled trials. Diabetes Obes Metab 20(2):458\u2013462. https:\/\/doi.org\/10.1111\/dom.13101","journal-title":"Diabetes Obes Metab"},{"issue":"7","key":"1513_CR10","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/bdd.1909","volume":"35","author":"Y Chino","year":"2014","unstructured":"Chino Y, Samukawa Y, Sakai S, Nakai Y, Yamaguchi J, Nakanishi T, Tamai I (2014) SGLT2 inhibitor lowers serum uric acid through alteration of uric acid transport activity in renal tubule by increased glycosuria. Biopharm Drug Dispos 35(7):391\u2013404. https:\/\/doi.org\/10.1002\/bdd.1909","journal-title":"Biopharm Drug Dispos"},{"issue":"11","key":"1513_CR11","doi-asserted-by":"publisher","first-page":"825","DOI":"10.7326\/0003-4819-158-11-201306040-00007","volume":"158","author":"Stevens PE, Levin A, Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members","year":"2013","unstructured":"Stevens PE, Levin A, Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members (2013) Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med 158(11):825\u2013830. https:\/\/doi.org\/10.7326\/0003-4819-158-11-201306040-00007","journal-title":"Ann Intern Med"},{"issue":"12","key":"1513_CR12","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1007\/s10554-016-0960-7","volume":"32","author":"G Song","year":"2016","unstructured":"Song G, Liu J, Qiao W, Chen Y, Sun L, Ren W, Li F, Fan M (2016) Regression equations of Z score and echocardiographic nomograms for coronary sinus in healthy children. Int J Cardiovasc Imaging 32(12):1687\u20131695. https:\/\/doi.org\/10.1007\/s10554-016-0960-7","journal-title":"Int J Cardiovasc Imaging"},{"issue":"10","key":"1513_CR13","doi-asserted-by":"publisher","first-page":"3136","DOI":"10.1002\/art.30520","volume":"63","author":"Y Zhu","year":"2011","unstructured":"Zhu Y, Pandya BJ, Choi HK (2011) Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007\u20132008. Arthritis Rheum 63(10):3136\u20133141. https:\/\/doi.org\/10.1002\/art.30520","journal-title":"Arthritis Rheum"},{"issue":"9","key":"1513_CR14","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J (2009) CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med 150(9):604\u2013612. https:\/\/doi.org\/10.7326\/0003-4819-150-9-200905050-00006","journal-title":"Ann Intern Med"},{"issue":"1","key":"1513_CR15","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12874-019-0667-2","volume":"19","author":"M Thoresen","year":"2019","unstructured":"Thoresen M (2019) Spurious interaction as a result of categorization. BMC Med Res Methodol 19(1):28. https:\/\/doi.org\/10.1186\/s12874-019-0667-2","journal-title":"BMC Med Res Methodol"},{"issue":"12","key":"1513_CR16","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1136\/ard.2010.130013","volume":"69","author":"G Rodr\u00edguez","year":"2010","unstructured":"Rodr\u00edguez G, Soriano LC, Choi HK (2010) Impact of diabetes against the future risk of developing gout. Ann Rheum Dis 69(12):2090\u20132094. https:\/\/doi.org\/10.1136\/ard.2010.130013","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"1513_CR17","doi-asserted-by":"publisher","first-page":"F77","DOI":"10.1152\/ajprenal.00555.2014","volume":"308","author":"Y Lytvyn","year":"2015","unstructured":"Lytvyn Y, \u0160krti\u0107 M, Yang GK, Yip PM, Perkins BA, Cherney DZ (2015) Glycosuria-mediated urinary uric acid excretion in patients with uncomplicated type 1 diabetes mellitus. Am J Physiol Renal Physiol 308(2):F77\u2013F83. https:\/\/doi.org\/10.1152\/ajprenal.00555.2014","journal-title":"Am J Physiol Renal Physiol"},{"issue":"7","key":"1513_CR18","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1111\/dme.13956","volume":"36","author":"J Chen","year":"2019","unstructured":"Chen J, Qiu SH, Guo HJ, Li W, Sun ZL (2019) Increased urinary glucose excretion is associated with a reduced risk of hyperuricaemia. Diabet Med 36(7):902\u2013907. https:\/\/doi.org\/10.1111\/dme.13956","journal-title":"Diabet Med"},{"issue":"32","key":"1513_CR19","doi-asserted-by":"publisher","first-page":"e1358","DOI":"10.1097\/MD.0000000000001358","volume":"94","author":"JM Wijnands","year":"2015","unstructured":"Wijnands JM, van Durme CM, Driessen JH, Boonen A, Klop C, Leufkens B, Cooper C, Stehouwer CD, de Vries F (2015) Individuals with type 2 diabetes mellitus are at an increased risk of gout but this is not due to diabetes: a population-based cohort study. Medicine (Baltimore) 94(32):e1358. https:\/\/doi.org\/10.1097\/MD.0000000000001358","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"1513_CR20","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.2215\/CJN.03140315","volume":"10","author":"S De Cosmo","year":"2015","unstructured":"De Cosmo S, Viazzi F, Pacilli A, Giorda C, Ceriello A, Gentile S, Russo G, Rossi MC, Nicolucci A, Guida P, Feig D, Johnson RJ, Pontremoli R, AMD-Annals Study Group (2015) Serum uric acid and risk of CKD in type 2 DIABETES. Clin J Am Soc Nephrol 10(11):1921\u20131929. https:\/\/doi.org\/10.2215\/CJN.03140315","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"1513_CR21","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/ki.2013.451","volume":"86","author":"RE Gilbert","year":"2014","unstructured":"Gilbert RE (2014) Sodium-glucose linked transporter-2 inhibitors: potential for renoprotection beyond blood glucose lowering? Kidney Int 86(4):693\u2013700. https:\/\/doi.org\/10.1038\/ki.2013.451","journal-title":"Kidney Int"},{"issue":"3","key":"1513_CR22","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.jcjd.2014.10.013","volume":"39","author":"Y Lytvyn","year":"2015","unstructured":"Lytvyn Y, Perkins BA, Cherney DZ (2015) Uric acid as a biomarker and a therapeutic target in diabetes. Can J Diabetes 39(3):239\u2013246. https:\/\/doi.org\/10.1016\/j.jcjd.2014.10.013","journal-title":"Can J Diabetes"},{"issue":"40","key":"1513_CR23","doi-asserted-by":"publisher","first-page":"26834","DOI":"10.1074\/jbc.C800156200","volume":"283","author":"N Anzai","year":"2008","unstructured":"Anzai N, Ichida K, Jutabha P, Kimura T, Babu E, Jin CJ, Srivastava S, Kitamura K, Hisatome I, Endou H, Sakurai H (2008) Plasma urate level is directly regulated by a voltage-driven urate efflux transporter URATv1 (SLC2A9) in humans. J Biol Chem 283(40):26834\u201326838. https:\/\/doi.org\/10.1074\/jbc.C800156200","journal-title":"J Biol Chem"},{"issue":"16","key":"1513_CR24","doi-asserted-by":"publisher","first-page":"16229","DOI":"10.1074\/jbc.M312226200","volume":"279","author":"R Augustin","year":"2004","unstructured":"Augustin R, Carayannopoulos MO, Dowd LO, Phay JE, Moley JF, Moley KH (2004) Identification and characterization of human glucose transporter-like protein-9 (GLUT9): alternative splicing alters trafficking. J Biol Chem 279(16):16229\u201316236. https:\/\/doi.org\/10.1074\/jbc.M312226200","journal-title":"J Biol Chem"},{"issue":"2","key":"1513_CR25","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1681\/ASN.2006040415","volume":"18","author":"Y Hagos","year":"2007","unstructured":"Hagos Y, Stein D, Ugele B, Burckhardt G, Bahn A (2007) Human renal organic anion transporter 4 operates as an asymmetric urate transporter. J Am Soc Nephrol 18(2):430\u2013439. https:\/\/doi.org\/10.1681\/ASN.2006040415","journal-title":"J Am Soc Nephrol"},{"issue":"24","key":"1513_CR26","doi-asserted-by":"publisher","first-page":"16332","DOI":"10.1074\/jbc.M800737200","volume":"283","author":"A Bahn","year":"2008","unstructured":"Bahn A, Hagos Y, Reuter S, Balen D, Brzica H, Krick W, Burckhardt BC, Sabolic I, Burckhardt G (2008) Identification of a new urate and high affinity nicotinate transporter, hOAT10 (SLC22A13). J Biol Chem 283(24):16332\u201316341. https:\/\/doi.org\/10.1074\/jbc.M800737200","journal-title":"J Biol Chem"},{"issue":"6","key":"1513_CR27","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1093\/ndt\/gfp740","volume":"25","author":"DI Jalal","year":"2010","unstructured":"Jalal DI, Rivard CJ, Johnson RJ, Maahs DM, McFann K, Rewers M, Snell-Bergeon JK (2010) Serum uric acid levels predict the development of albuminuria over 6 years in patients with type 1 diabetes: findings from the Coronary Artery Calcification in Type 1 Diabetes study. Nephrol Dial Transplant 25(6):1865\u20131869. https:\/\/doi.org\/10.1093\/ndt\/gfp740","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"1513_CR28","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1681\/ASN.2008010080","volume":"19","author":"RP Obermayr","year":"2008","unstructured":"Obermayr RP, Temml C, Gutjahr G, Knechtelsdorfer M, Oberbauer R, Klauser-Braun R (2008) Elevated uric acid increases the risk for kidney disease. J Am Soc Nephrol 19(12):2407\u20132413. https:\/\/doi.org\/10.1681\/ASN.2008010080","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"1513_CR29","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1053\/j.ajkd.2008.12.021","volume":"53","author":"M Madero","year":"2008","unstructured":"Madero M, Sarnak MJ, Wang X, Greene T, Beck GJ, Kusek JW, Collins AJ, Levey AS, Menon V (2008) Uric acid and long-term outcomes in CKD. Am J Kidney Dis 53(5):796\u2013803. https:\/\/doi.org\/10.1053\/j.ajkd.2008.12.021","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"1513_CR30","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1053\/j.ajkd.2005.10.006","volume":"47","author":"YP Siu","year":"2006","unstructured":"Siu YP, Leung KT, Tong MK, Kwan TH (2006) Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Am J Kidney Dis 47(1):51\u201359. https:\/\/doi.org\/10.1053\/j.ajkd.2005.10.006","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"1513_CR31","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1053\/j.ajkd.2014.11.016","volume":"65","author":"M Goicoechea","year":"2015","unstructured":"Goicoechea M, Garcia de Vinuesa S, Verdalles U, Verde E, Macias N, Santos A, P\u00e9rez de Jose A, Cede\u00f1o S, Linares T, Lu\u00f1o J (2015) Allopurinol and progression of CKD and cardiovascular events: long-term follow-up of a randomized clinical trial. Am J Kidney Dis 65(4):543\u2013549. https:\/\/doi.org\/10.1053\/j.ajkd.2014.11.016","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"1513_CR32","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.2215\/CJN.01580210","volume":"5","author":"M Goicoechea","year":"2010","unstructured":"Goicoechea M, de Vinuesa SG, Verdalles U, Ruiz-Caro C, Ampuero J, Rinc\u00f3n A, Arroyo D, Lu\u00f1o J (2010) Effect of allopurinol in chronic kidney disease progression and cardiovascular risk. Clin J Am Soc Nephrol 5(8):1388\u20131393. https:\/\/doi.org\/10.2215\/CJN.01580210","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"1513_CR33","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1053\/j.ajkd.2015.05.017","volume":"66","author":"D Sircar","year":"2015","unstructured":"Sircar D, Chatterjee S, Waikhom R, Golay V, Raychaudhury A, Chatterjee S, Pandey R (2015) Efficacy of febuxostat for slowing the GFR decline in patients with ckd and asymptomatic hyperuricemia: a 6-month, double-blind, randomized, Placebo-Controlled Trial. Am J Kidney Dis 66(6):945\u2013950. https:\/\/doi.org\/10.1053\/j.ajkd.2015.05.017","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"1513_CR34","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1093\/ndt\/gft378","volume":"29","author":"B Bose","year":"2014","unstructured":"Bose B, Badve SV, Hiremath SS, Boudville N, Brown FG, Cass A, de Zoysa JR, Fassett RG, Faull R, Harris DC, Hawley CM, Kanellis J, Palmer SC, Perkovic V, Pascoe EM, Rangan GK, Walker RJ, Walters G, Johnson DW (2014) Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysis. Nephrol Dial Transplant 29(2):406\u2013413. https:\/\/doi.org\/10.1093\/ndt\/gft378","journal-title":"Nephrol Dial Transplant"},{"issue":"26","key":"1513_CR35","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1056\/NEJMoa1915833","volume":"382","author":"SV Badve","year":"2020","unstructured":"Badve SV, Pascoe EM, Tiku A, Boudville N, Brown FG, Cass A, Clarke P, Dalbeth N, Day RO, de Zoysa JR, Douglas B, Faull R, Harris DC, Hawley CM, Jones GRD, Kanellis J, Palmer SC, Perkovic V, Rangan GK, Reidlinger D, Robison L, Walker RJ, Walters G, Johnson DW, CKD-FIX Study Investigators (2020) Effects of allopurinol on the progression of chronic kidney disease. N Engl J Med 382(26):2504\u20132513. https:\/\/doi.org\/10.1056\/NEJMoa1915833","journal-title":"N Engl J Med"},{"issue":"26","key":"1513_CR36","doi-asserted-by":"publisher","first-page":"2493","DOI":"10.1056\/NEJMoa1916624","volume":"382","author":"A Doria","year":"2020","unstructured":"Doria A, Galecki AT, Spino C, Pop-Busui R, Cherney DZ, Lingvay I, Parsa A, Rossing P, Sigal RJ, Afkarian M, Aronson R, Caramori ML, Crandall JP, de Boer IH, Elliott TG, Goldfine AB, Haw JS, Hirsch IB, Karger AB, Maahs DM, McGill JB, Molitch ME, Perkins BA, Polsky S, Pragnell M, Robiner WN, Rosas SE, Senior P, Tuttle KR, Umpierrez GE, Wallia A, Weinstock RS, Wu C, Mauer M, PERL Study Group (2020) Serum urate lowering with allopurinol and kidney function in type 1 diabetes. N Engl J Med 382(26):2493\u20132503. https:\/\/doi.org\/10.1056\/NEJMoa1916624","journal-title":"N Engl J Med"},{"issue":"5","key":"1513_CR37","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/j.kint.2016.11.025","volume":"91","author":"AJ Ahola","year":"2017","unstructured":"Ahola AJ, Sandholm N, Forsblom C, Harjutsalo V, Dahlstr\u00f6m E, Groop PH, FinnDiane Study Group (2017) The serum uric acid concentration is not causally\u00a0linked\u00a0to\u00a0diabetic nephropathy in type 1 diabetes. Kidney Int 91(5):1178\u20131185. https:\/\/doi.org\/10.1016\/j.kint.2016.11.025","journal-title":"Kidney Int"},{"issue":"1","key":"1513_CR38","doi-asserted-by":"publisher","first-page":"e1002725","DOI":"10.1371\/journal.pmed.1002725","volume":"16","author":"DM Jordan","year":"2019","unstructured":"Jordan DM, Choi HK, Verbanck M, Topless R, Won HH, Nadkarni G, Merriman TR, Do R (2019) No causal effects of serum urate levels on the risk of chronic kidney disease: A Mendelian randomization study. PLoS Med 16(1):e1002725. https:\/\/doi.org\/10.1371\/journal.pmed.1002725","journal-title":"PLoS Med"},{"issue":"10","key":"1513_CR39","doi-asserted-by":"publisher","first-page":"e1002937","DOI":"10.1371\/journal.pmed.1002937","volume":"16","author":"X Li","year":"2019","unstructured":"Li X, Meng X, He Y, Spiliopoulou A, Timofeeva M, Wei WQ, Gifford A, Yang T, Varley T, Tzoulaki I, Joshi P, Denny JC, Mckeigue P, Campbell H, Theodoratou E (2019) Genetically determined serum urate levels and cardiovascular and other diseases in UK Biobank cohort: A phenome-wide mendelian randomization study. PLoS Med 16(10):e1002937. https:\/\/doi.org\/10.1371\/journal.pmed.1002937","journal-title":"PLoS Med"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-021-01513-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-021-01513-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-021-01513-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T10:09:27Z","timestamp":1628676567000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-021-01513-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,29]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["1513"],"URL":"https:\/\/doi.org\/10.1007\/s40618-021-01513-8","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,29]]},"assertion":[{"value":"31 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (Institutional and National) and with the Helsinki Declaration of 1964 and later versions.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"Informed consent was obtained from all patients for being included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}